NEPHROPLUS.NS
NEPHROPLUS · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for NEPHROPLUS.NS quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Copy of Newspaper Publication
17 Jul 2026
General Updates
17 Jul 2026
Shareholders meeting
17 Jul 2026
Copy of Newspaper Publication
16 Jul 2026
Options to purchase securities
15 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
07 Jul 2026
Giving guarantees/indemnity/ becoming a surety for third party
06 Jul 2026
Giving guarantees/indemnity/ becoming a surety for third party
25 Jun 2026
Agreements
25 Jun 2026
Agreements
23 Jun 2026
Options to purchase securities
23 Jun 2026
Trading Window
19 Jun 2026
Disclosure under SEBI Takeover Regulations
19 Jun 2026
Disclosure under SEBI Takeover Regulations
18 Jun 2026
Disclosure under SEBI Takeover Regulations
18 Jun 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
No corporate actions available from NSE right now.
Board Meetings
19 May 2026
NEPHROCARE HEALTH SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 19-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 .
19 May 2026
To consider and approve the audited financial results for the quarter and financial year ended March 31, 2026
10 Feb 2026
NEPHROCARE HEALTH SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
10 Feb 2026
To consider and approve the financial results for the period ended December 31, 2025